Skip to Main Content

Author Details

Mahdad Noursadeghi
University College London
1992
149
46
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36683708<i>Streptococcus pneumoniae</i> meningitis and the CNS barriers.Front Cell Infect Microbiol2023
37612310Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.Nat Commun2023
37286216Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis.Eur Respir Rev2023
37275518Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.iScience2023
37333303Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study.medRxiv2023
37397982Blood RNA biomarkers for tuberculosis screening in people living with HIV prior to anti-retroviral therapy initiation: A diagnostic accuracy study.medRxiv2023
36697826Tissue CD14<sup>+</sup>CD8<sup>+</sup> T cells reprogrammed by myeloid cells and modulated by LPS.Nature2023
34810237Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol.Thorax2022
35474751Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.Cell Rep Med2022
35835695Pneumolysin suppresses the initial macrophage pro-inflammatory response to Streptococcus pneumoniae.Immunology2022
35699621Immune boosting by B.1.1.529 <b>(</b>Omicron) depends on previous SARS-CoV-2 exposure.Science2022
35820692Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysis.BMJ2022
36543100Toward a more generalizable blood RNA signature for bacterial and viral infections.Cell Rep Med2022
36182629Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection.EBioMedicine2022
35967850<i>Streptococcus pneumoniae</i> interactions with the complement system.Front Cell Infect Microbiol2022
35967327Pericyte derived chemokines amplify neutrophil recruitment across the cerebrovascular endothelial barrier.Front Immunol2022
35156709HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19.Immunology2022
35128501Antiviral metabolite 3'-deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19.Med2022
34855510Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.Science2022
34942634Evolution of enhanced innate immune evasion by SARS-CoV-2.Nature2022
35332335Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.Nature2022
33319166Transcriptional response modules characterize IL-1β and IL-6 activity in COVID-19.iScience2021
33880438Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk.EClinicalMedicine2021
33732256Persistent T Cell Repertoire Perturbation and T Cell Activation in HIV After Long Term Treatment.Front Immunol2021
33640038Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.Lancet2021
33862011Blood transcriptomic biomarkers for tuberculosis screening: time to redefine our target populations?Lancet Glob Health2021
33611594Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic.Eur J Prev Cardiol2021
33931567Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.Science2021
33662833Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARSâ¿¿CoV-2 infection.EBioMedicine2021
34925266Aggregated <i>Mycobacterium tuberculosis</i> Enhances the Inflammatory Response.Front Microbiol2021
34705613New Insights into the Limitations of Host Transcriptional Biomarkers of Tuberculosis.Am J Respir Crit Care Med2021
34545952Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies.Br J Haematol2021
34423323Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case-control and observational cohort study.Lancet Microbe2021
34250515Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.Lancet Microbe2021
34127972Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant.bioRxiv2021
34101213SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.EMBO J2021
34100007Detection of Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic tuberculosis contacts: an observational study.Lancet Microbe2021
34244287Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study.BMJ Open2021
33952677Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease.Sci Transl Med2021
33975819Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers.JACC Cardiovasc Imaging2021
33975252Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis.EBioMedicine2021
33421909NIX-mediated mitophagy regulate metabolic reprogramming in phagocytic cells during mycobacterial infection.Tuberculosis (Edinb)2021
33472631Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study.BMC Med2021
30919880Blood Transcriptomic Stratification of Short-term Risk in Contacts of Tuberculosis.Clin Infect Dis2020
36284901Vitamin D<sub>3</sub> replacement enhances antigen-specific immunity in older adults.Immunother Adv2020
32083944Evaluation of QuantiFERON-TB Gold Plus for Predicting Incident Tuberculosis among Recent Contacts: A Prospective Cohort Study.Ann Am Thorac Soc2020
32081863Analysis tools to quantify dissemination of pathology in zebrafish larvae.Sci Rep2020
31958400Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis.Lancet Respir Med2020
31825645Quantitative IFN-γ Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis. A Prospective Cohort Study.Am J Respir Crit Care Med2020
32106253Viral infection triggers interferon-induced expulsion of live Cryptococcus neoformans by macrophages.PLoS Pathog2020
  • 1 - 50 of 149

Recommended Authors

Massachusetts Institute of Technology, USA The Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 1
University of Alabama at Birmingham Birmingham
Career Start Year 2011
Number of shared co-authors 0
Sorbonne University INSERM
Career Start Year 2010
Number of shared co-authors 0
University of Pennsylvania Perelman School of Medicine
Career Start Year 2006
Number of shared co-authors 1
College of Osteopathic Medicine, Michigan State University
Career Start Year 2006
Number of shared co-authors 1
Cardiovascular Research Institute, University of California san francisco
Career Start Year 2006
Number of shared co-authors 1
Stanford University
Career Start Year 2006
Number of shared co-authors 2
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2006
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
NanoString Technologies Inc.
Career Start Year 2002
Number of shared co-authors 0
Seattle Children's Research Institute
Career Start Year 2002
Number of shared co-authors 0
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 3
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 1
Frazer Institute, The University of Queensland
Career Start Year 2001
Number of shared co-authors 2
Genentech Inc.
Career Start Year 2000
Number of shared co-authors 0
Duke University School of Medicine
Career Start Year 1998
Number of shared co-authors 1
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 1
Chest & Allergy clinic, Imperial College Healthcare NHS Trust, St Mary's Hospital
Career Start Year 1996
Number of shared co-authors 3
Ragon Institute of MGH
Career Start Year 1995
Number of shared co-authors 3
Lausanne University Hospital
Career Start Year 1994
Number of shared co-authors 2
Yale University
Career Start Year 1990
Number of shared co-authors 4
London School of Hygiene and Tropical Medicine
Career Start Year 1989
Number of shared co-authors 4
University Medical Center Utrecht
Career Start Year 1988
Number of shared co-authors 1
University of Pennsylvania School of Medicine
Career Start Year 1988
Number of shared co-authors 1
University of California san francisco
Career Start Year 1986
Number of shared co-authors 2
UK System Immunity Research Institute, Cardiff University
Career Start Year 1985
Number of shared co-authors 2
University of Massachusetts Chan Medical School
Career Start Year 1982
Number of shared co-authors 0
Public Health Research Institute, Rutgers New Jersey Medical School
Career Start Year 1980
Number of shared co-authors 0
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 5
Wistar Institute
Career Start Year 1958
Number of shared co-authors 1

Collaborators

University College London
Co-authored papers 14
University College London
Co-authored papers 5
University College London
Co-authored papers 5
University College London
Co-authored papers 4
Institute of Health Informatics, University College London
Co-authored papers 4
University College London
Co-authored papers 4
University College London
Co-authored papers 4
J. David Gladstone Institutes
Co-authored papers 4
University of Cambridge
Co-authored papers 3
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 3
University of Cambridge, Addenbrooke's Hospital Level 5
Co-authored papers 3
J. David Gladstone Institutes
Co-authored papers 3
University of California, San Francisco
Co-authored papers 3
Cardiovascular Research Institute, University of California San Francisco
Co-authored papers 3
J. David Gladstone Institutes
Co-authored papers 3
Fred Hutchinson Cancer Center
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
University of Ottawa
Co-authored papers 3
J. David Gladstone Institutes
Co-authored papers 3
University of California, University of California San Francisco
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
J. David Gladstone Institutes
Co-authored papers 3
University of Wisconsin-Madison
Co-authored papers 3
University of Cambridge
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
University of Nottingham
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
European Bioinformatics Institute
Co-authored papers 3
Massachusetts Institute of Technology
Co-authored papers 2